Xuelian Liu

Title: Innovations of Xuelian Liu in Pharmaceutical Development

Introduction

Xuelian Liu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. With a total of two patents to his name, Liu's work is focused on innovative solutions for medical challenges.

Latest Patents

Xuelian Liu's latest patents include a compound for inhibiting and inducing degradation of EGFR kinase. This invention provides an EGFR kinase inhibitor according to a general formula and a pharmaceutical composition containing the inhibitor. The invention can be utilized to treat diseases related to EGFR kinase, such as cancer. Another notable patent is related to a solid form of a diaminopyrimidine compound or its hydrate. This invention encompasses a method for preparing the solid form, a pharmaceutical composition comprising the solid form, and its application for the prevention or treatment of diseases modulated by P2X3 and/or P2X2/3 receptor antagonists.

Career Highlights

Xuelian Liu is currently associated with Beijing Tide Pharmaceutical Co., Ltd. His work at this company has allowed him to focus on the development of innovative pharmaceutical solutions. Liu's expertise in the field has positioned him as a valuable contributor to advancements in medical treatments.

Collaborations

Some of Xuelian Liu's coworkers include Yanping Zhao and Hongjun Wang. Their collaboration in research and development has further enhanced the innovative capabilities of their team.

Conclusion

Xuelian Liu's contributions to pharmaceutical innovations demonstrate his commitment to addressing critical health issues through scientific advancements. His patents reflect a dedication to improving treatment options for patients, particularly in the realm of cancer and receptor antagonists.